Cartessa Aesthetics Brings Aesthetic Devices to Canada 

Cartessa Aesthetics is expanding its Canadian portfolio with the launch of four new technologies, HELIX, TORO, EVERESSE, and ULTRAFORMER MPT, according to a press release from the manufacturer.  

The new devices are expected to give Canadian providers access to some of the most advanced, in-demand tools on the market, backed by global success and proven results. The HELIX technology was developed with Cartessa partner DEKA and builds on the TetraPro CO₂ laser, introducing a powerful 1570 nm fiber laser for customizable ablative and non-ablative resurfacing, plus exclusive CoolPeel^TM capabilities with no social downtime.  

“The response to HELIX in the US has been phenomenal,” said Gabe Lubin, Cartessa Aesthetics founder, in the news release. “The addition of a non-ablative wavelength to the already versatile #1 CO₂ technology has given providers more ways to get more energy into the skin without increasing downtime. Die-hard Tetra owners are transitioning to HELIX and are not looking back.”  

TORO technology is new to North America, offering providers four pulse modes and three true wavelengths to address pigment, ink, and select superficial skin concerns with one highly precise and powerful device. 

The EVERESSE and ULTRAFORMER MPT marks the official debut of Classys Inc. in Canada. EVERESSE technology delivers advanced monopolar radiofrequency to lift, volumize, and smooth skin, offering a more comfortable alternative to traditional monopolar radiofrequency. ULTRAFORMER MPT is a HIFU device that delivers precise, multi-depth facial lifting from the dermis to the SMAS layer with unmatched comfort and speed.  

“We are thrilled to partner with Cartessa to introduce not one, but two leading Classys technologies to the Canadian aesthetic market,” Seung Han Baek, CEO of Classys Inc., said in the press release. “With over 3,000 EVERESSE and 18,000 ULTRAFORMER devices installed globally, we are confident that Canadian providers and their patients will embrace the exceptional clinical outcomes and recognized the difference versus what’s been available to them.”  

Source: Cartessa Aesthetics press release, May 28, 2025.